Cite
APA Citation
Lawitz, E. J., Hill, J. M., Marbury, T., DeMicco, M. P., Delaney, W., Yang, J., Moorehead, L., Mathias, A., Mo, H., McHutchison, J. G., Rodriguez-Torres, M., & Gordon, S. C. (2013). a Phase I, Randomized, Placebo-Controlled, 3-Day, Ascending-Dose Study of Gs-9451, An Ns3/4A Protease Inhibitor, in Genotype 1 Hepatitis C Patients. Antiviral therapy, 18(3), 311–319. http://access.bl.uk/ark:/81055/vdc_100170289043.0x00000c